首页> 中文期刊>国际感染杂志(电子版) >Inhibition on IFN-βExpression by hCV ns3 and ns5A in HepG2 Cells

Inhibition on IFN-βExpression by hCV ns3 and ns5A in HepG2 Cells

     

摘要

Objective To observe the effects of HCV protein, NS3 and NS5A on IFN-βin HepG2 cells and its regulation mechanism. Methods Human liver hepatocellular carcinoma cells HepG2 were transfected with recombinant eukaryotic plasmid pcDNA3.1/myc-His-core, NS3 or NS5A to overexpress these proteins, and the expression of IFN-βwere detected by qRT-PCR, Western blotting and ELISA. Luc2P reporter plasmids pGL4.10-IFNβ-P were constructed and transfected into HepG2 cells, and the activity of IFN-βpromoter were determined through luciferase assay for regulation mechanism study. Results Both mRNA level and protein expression of IFN-β were significantly decreased (P < 0.05) in the presence of NS3 or NS5A protein. Luciferase assay revealed that NS3 or NS5A protein downregulated IFN-βpromoter activity (P< 0.05). Meanwhile, HCV core protein had little effect on IFN-βexpression. Conclusions HCV protein NS3 and NS5A could inhibit innate IFN-β expression and thus escape immune selection and hinder the host immune responses.

著录项

  • 来源
    《国际感染杂志(电子版)》|2013年第1期|29-35|共7页
  • 作者单位

    Beijing Ditan Hospital, Peking University Teaching Hospital, Beijing 100015, China;

    Institute of Infectious Diseases, Capital Medical University, Beijing Ditan Hospital, Beijing 100015, China;

    Institute of Infectious Diseases, Capital Medical University, Beijing Ditan Hospital, Beijing 100015, China;

    Institute of Infectious Diseases, Capital Medical University, Beijing Ditan Hospital, Beijing 100015, China;

    Beijing Ditan Hospital, Peking University Teaching Hospital, Beijing 100015, China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号